Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Now, Smith claims that Christopher’s body is on display at Las Vegas’ Real Bodies Exhibition, which showcases human bodies ...

Geotab Inc. and its affiliates ("Geotab"), a global leader in connected vehicle and asset solutions, today announced a collaboration with Thermo King, a leader in sustainable transport temperature ...

Bempikibart demonstrated positive, durable responses among patients with severe to very severe alopecia areata, according to ...

The IRA was passed in 2022 during former President Joe Biden's term, leaving some in the pharma industry to hope that the new Trump administration may tweak the program. Last month, the Centers ...

Shift Biosciences, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, ...

The Atlanta Fed GDP Now forecast for Q1 GDP growth has crashed from its initial estimate of nearly 4% growth to just 2.3%.

King was supported by the firm’s counsel in Tokyo ... seen advising in Boston-based Bain Capital’s $3.3 billion acquisition ...

Learn More » Recursion Pharmaceuticals (NASDAQ ... and could speak the truth to the king -- without getting their heads lopped off. This data feed is not available at this time.

Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25Phase 3 CAPTIVATE trial of ...

Lexon had appealed against a ruling by the UK’s Competition and Markets Authority (CMA) that it had exchanged information with King Pharmaceuticals and Alissa Healthcare Research in order to ...

Although sequels rarely surpass the original, Gavin O'Connor's long-gestating 'The Accountant 2' is a pleasant surprise.